Access to antiretroviral therapy in HIV-infected children aged 0–19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004–2015: A prospective cohort study

Abstract

IntroductionAccess to antiretroviral therapy (ART) is a global priority. However, the attrition across the continuum of care for HIV-infected children between their HIV diagnosis and ART initiation is not well known. We analyzed the time from enrollment into HIV care to ART initiation in HIV-infected children within the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium.Methods and findingsWe included 135,479 HIV-1-infected children, aged 0–19 years and ART-naïve at enrollment, between 1 January 2004 and 31 December 2015, in IeDEA cohorts from Central Africa (3 countries; n = 4,948), East Africa (3 countries; n = 22,827), West Africa (7 countries; n = 7,372), Southern Africa (6 countries; n = 93,799), Asia-Pacific (6 countries; n = 4,045), and Latin America (7 countries; n = 2,488). Follow-up in these cohorts is typically every 3–6 months. We described time to ART initiation and missed opportunities (death or loss to follow-up [LTFU]: last clinical visit >6 months) since baseline (the date of HIV diagnosis or, if unavailable, date of enrollment). Cumulative incidence functions (CIFs) for and determinants of ART initiation were computed, with death and LTFU as competing risks. Among the 135,479 children included, 99,404 (73.4%) initiated ART, 1.9% died, 1.4% were transferred out, and 20.4% were lost to follow-up before ART initiation. The 24-month CIF for ART initiation was 68.2% (95% CI: 67.9%–68.4%); it was lower in sub-Saharan Africa—ranging from 49.8% (95% CI: 48.4%–51.2%) in Central Africa to 72.5% (95% CI: 71.5%–73.5%) in West Africa—compared to Latin America (71.0%, 95% CI: 69.1%–72.7%) and the Asia-Pacific (78.3%, 95% CI: 76.9%–79.6%). Adolescents aged 15–19 years and infants <1 year had the lowest cumulative incidence of ART initiation compared to other ages: 62.2% (95% CI: 61.6%–62.8%) and 66.4% (95% CI: 65.7%–67.0%), respectively. Overall, 49.1% were ART-eligible per local guidelines at baseline, of whom 80.6% initiated ART. The following children had lower cumulative incidence of ART initiation: female children (p < 0.01); those aged <1 year, 2–4 years, 5–9 years, and 15–19 years (versus those aged 10–14 years, p < 0.01); those who became eligible during follow-up (versus eligible at enrollment, p < 0.01); and those receiving care in low-income or lower-middle-income countries (p < 0.01). The main limitations of our study include left truncation and survivor bias, caused by deaths of children prior to enrollment, and use of enrollment date as a proxy for missing data on date of HIV diagnosis, which could have led to underestimation of the time between HIV diagnosis and ART initiation.ConclusionsIn this study, 68% of HIV-infected children initiated ART by 24 months. However, there was a substantial risk of LTFU before ART initiation, which may also represent undocumented mortality. In 2015, many obstacles to ART initiation remained, with substantial inequities. More effective and targeted interventions to improve access are needed to reach the target of treating 90% o...

Stunting and growth velocity of adolescents with perinatally acquired HIV: differential evolution for males and females. A multiregional analysis from the IeDEA global paediatric collaboration

“…Even on ART, chronic immunodeficiency could alter growth . We observed a trend of poorer growth evolution among males attending rural clinics, which suggests higher vulnerability of APH living in rural settings that could be related to poverty and food access as well as the general challenges of ART adherence and retention in HIV care observed during adolescence .…”

Research priorities to inform “Treat All” policy implementation for people living with HIV in sub‐Saharan Africa: a consensus statement from the International epidemiology Databases to Evaluate AIDS (IeDEA)

“…Men, adolescents, those with lower education levels, and the poorest individuals are less likely to be aware of their status, resulting in late initiation of treatment, as well as lower and later attainment of viral suppression . Infants less than 18 months of age are also at risk of delays in care enrollment and treatment initiation because of challenges in early infant diagnosis testing, especially in resource‐limited settings . Estimating the “first 90” for key populations (e.g.…”

“… Context: Global data suggest that the timeliness of ART initiation, as measured by the level of immunodeficiency at the start of ART, is highly suboptimal in relation to WHO guidelines, particularly in SSA, where a recent analysis of data from 767,000 patients in 21 countries showed that median CD4 counts at ART initiation remained below 300 cells/mm 3 in 2015 . Infants, adolescents, and men, in particular, are more likely to initiate treatment late and to not be retained in care . Research approaches : Important factors for further study include quality of care; policy and administrative requirements; costs of services, including user fees; HIV‐related stigma; integrated screening and treatment of other health conditions (i.e. non‐communicable diseases); and community‐ and home‐based services (e.g.…”

Rapid antiretroviral initiation among Thai youth living with HIV in the National AIDS programme in the era of treatment at any CD4 cell count: a national registry database study

“…Meanwhile, the IeDEA Global Cohort, which is comprised of cohorts with different infrastructures, reported that overall N a t r i s k 0 1 2 3 4 5 6 7 8 9 1 0 1 1 1 2 2008-2013 21825 15648 13447 12406 11716 11290 10986 10716 10454 10244 10059 9913 9763 2014-2018 29782 14174 10160 8679 7843 7284 6853 6468 6118 5829 5594 LTFU (defined as clinic absence of >6 months) before starting ART was 20.4%, but only 2.3% in the Asia-Pacific region [35]. The majority of Asian cohorts in the IeDEA study were from research centres that specifically cater for YLHIV.…”